Adult Sickle Cell Center, Division of Hematology-Oncology, University of Connecticut Health Center, Farmington, Connecticut.
Pediatr Blood Cancer. 2014 Apr;61(4):697-701. doi: 10.1002/pbc.24870. Epub 2013 Dec 18.
A successful transition from pediatric to adult sickle cell disease (SCD) care is paramount to continued improvements in survival. In order to enhance transition success, our pediatric SCD transition process was modified to include combined adult and pediatric provider clinics that incorporated participation by our local SCD community-based organization. All children ages 16 and over participated in this newly-formed transition program.
After 5 years of implementation of the modified SCD transition program, we retrospectively studied clinical and non-clinical risk factors for an unsuccessful transition. Risk factor categories studied included patient demographics, transition clinic attendance, and disease severity.
Thirty-two percent of patients did not transition successfully. Demographic factors such as gender, race, and type of insurance did not influence transition outcome, although travel distance to the adult SCD center was an identifiable risk factor for an unsuccessful transition. While transition clinic attendance rate did not affect transition outcomes, older age at first modified combined transition clinic visit was a significant risk factor for lack of transition. Patients with clinical markers of milder disease severity (SC and Sβ(+) genotypes and no chronic transfusion therapy) were at higher risk for an unsuccessful transition than patients with severe disease.
We have identified several risk factors for lack of transition success which will allow us to modify our transition efforts going forward to capture this highest risk subset.
从儿科到成人镰状细胞病(SCD)护理的成功过渡对于提高生存率至关重要。为了提高过渡的成功率,我们对儿科 SCD 过渡流程进行了修改,包括结合了我们当地 SCD 社区组织参与的成人和儿科提供者诊所。所有 16 岁及以上的儿童都参加了这个新成立的过渡项目。
在实施改良的 SCD 过渡计划 5 年后,我们回顾性地研究了导致过渡失败的临床和非临床风险因素。研究的风险因素类别包括患者人口统计学、过渡诊所就诊情况和疾病严重程度。
32%的患者过渡不成功。人口统计学因素,如性别、种族和保险类型,并不影响过渡结果,尽管到成人 SCD 中心的旅行距离是过渡失败的一个可识别的风险因素。虽然过渡诊所就诊率并不影响过渡结果,但首次改良联合过渡诊所就诊时年龄较大是过渡失败的一个显著风险因素。疾病严重程度较轻的临床标志物(SC 和 Sβ(+)基因型,无慢性输血治疗)的患者比疾病严重的患者更有可能过渡失败。
我们已经确定了一些导致过渡失败的风险因素,这将使我们能够修改我们的过渡工作,以吸引这一最高风险人群。